111 related articles for article (PubMed ID: 15069718)
1. In vitro antitumor immune response induced by fusion of dendritic cells and colon cancer cells.
Xu F; Ye YJ; Wang S
World J Gastroenterol; 2004 Apr; 10(8):1162-6. PubMed ID: 15069718
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic dendritomas induce anti-tumour immunity against metastatic colon cancer.
Xu F; Ye YJ; Cui ZR; Wang S
Scand J Immunol; 2005 Apr; 61(4):364-9. PubMed ID: 15853920
[TBL] [Abstract][Full Text] [Related]
3. [In vitro antitumor immune response induced by fusion of dendritic cells and Ewing's sarcoma cells].
Tang S; Guo W; Guo Y; Qu HY; Li DS
Zhonghua Wai Ke Za Zhi; 2005 Jun; 43(12):803-6. PubMed ID: 16083585
[TBL] [Abstract][Full Text] [Related]
4. [Dendritomas plays an important role in the activation of anti-tumor immune responses].
Xu F; Wang S; Ye YJ
Zhonghua Yi Xue Za Zhi; 2004 May; 84(9):725-9. PubMed ID: 15200907
[TBL] [Abstract][Full Text] [Related]
5. [Inducing hepatocellular carcinoma-specific cytotoxic T lymphocyte response using formed by fusion of FastDCs and allogeneic human hepatocellular carcinoma cells].
Guan X; Leng XS; Peng JR; Wei YH; Wang H; Yuan L
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3332-6. PubMed ID: 16409838
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.
Yasuda T; Kamigaki T; Nakamura T; Imanishi T; Hayashi S; Kawasaki K; Takase S; Ajiki T; Kuroda Y
Oncol Rep; 2006 Dec; 16(6):1317-24. PubMed ID: 17089056
[TBL] [Abstract][Full Text] [Related]
7. Dendritic-tumor cell hybrids induce tumor-specific immune responses more effectively than the simple mixture of dendritic and tumor cells.
Pinho MP; Sundarasetty BS; Bergami-Santos PC; Steponavicius-Cruz K; Ferreira AK; Stripecke R; Barbuto JA
Cytotherapy; 2016 Apr; 18(4):570-80. PubMed ID: 26971685
[TBL] [Abstract][Full Text] [Related]
8. A novel, rapid strategy to form dendritomas from human dendritic cells and hepatocellular carcinoma cell line HCCLM3 cells using mature dendritic cells derived from human peripheral blood CD14+ monocytes within 48 hours of in vitro culture.
Guan X; Peng JR; Yuan L; Wang H; Wei YH; Leng XS
World J Gastroenterol; 2004 Dec; 10(24):3564-8. PubMed ID: 15534907
[TBL] [Abstract][Full Text] [Related]
9. [Antitumor response induced by vaccine of autologous dendritic/tumor fusion cells against renal cell].
Zhou J; Xia JC; Wang H; Wang QJ; Huang LX; Li YQ; Chen SP; Zhou FJ
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):411-4. PubMed ID: 17974271
[TBL] [Abstract][Full Text] [Related]
10. Preventive antitumor activity against hepatocellular carcinoma (HCC) induced by immunization with fusions of dendritic cells and HCC cells in mice.
Homma S; Toda G; Gong J; Kufe D; Ohno T
J Gastroenterol; 2001 Nov; 36(11):764-71. PubMed ID: 11757749
[TBL] [Abstract][Full Text] [Related]
11. Autologous dendritic cells loaded with apoptotic tumor cells induce T cell-mediated immune responses against breast cancer in vitro.
Delirezh N; Moazzeni SM; Shokri F; Shokrgozar MA; Atri M; Kokhaei P
Cell Immunol; 2009; 257(1-2):23-31. PubMed ID: 19306994
[TBL] [Abstract][Full Text] [Related]
12. Induction of specific cytolytic T lymphocytes using fusions of hepatocellular carcinoma (HCC) patient-derived dendritic cells and allogeneic HCC cell line.
Yin XY; Wang L; Lu MD; Li BJ; Huang JF
Hepatogastroenterology; 2008; 55(81):155-9. PubMed ID: 18507097
[TBL] [Abstract][Full Text] [Related]
13. [Antitumor efficacy of fusion cells from esophageal carcinoma cells and dendritic cells as a vaccine in vitro].
Deng YJ; Xia JC; Zhou J; Wang QJ; Zhang PY; Zhang LJ; Rong TH
Ai Zheng; 2007 Feb; 26(2):137-41. PubMed ID: 17298741
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cells engineered to secrete anti-DcR3 antibody augment cytotoxic T lymphocyte response against pancreatic cancer
Chen J; Guo XZ; Li HY; Zhao JJ; Xu WD
World J Gastroenterol; 2017 Feb; 23(5):817-829. PubMed ID: 28223726
[TBL] [Abstract][Full Text] [Related]
15. Preparation of fully activated dendritic cells capable of priming tumor-specific cytotoxic T lymphocytes in patients with metastatic cancer using penicillin-killed streptococcus pyogenes (OK432) and anti-CD40 antibody.
Kontani K; Teramoto K; Ozaki Y; Sawai S; Tezuka N; Ishida H; Kajino K; Fujino S; Yamauchi A; Taguchi O; Kannagi R; Yokomise H; Ogasawara K
Oncol Rep; 2007 Apr; 17(4):895-902. PubMed ID: 17342333
[TBL] [Abstract][Full Text] [Related]
16. Enhanced induction of anti-tumor CTLs in vitro by a lentivirus-transduced dendritic cell vaccine expressing secondary lymphoid tissue chemokine and mucin 1.
Wang B; Zhu Y; Zhang JJ; Chen Z; Liang WB; Xu ZK
Asian Pac J Cancer Prev; 2011; 12(11):2811-7. PubMed ID: 22393946
[TBL] [Abstract][Full Text] [Related]
17. Induction of cytotoxic T lymphocytes against human cancer cell lines using dendritic cell-tumor cell hybrids generated by a newly developed electrofusion technique.
Imura K; Ueda Y; Hayashi T; Itoh T; Shimizu K; Tamai H; Yano Y; Naito K; Kohara J; Nakane K; Matsuura Y; Takeda A; Takeda T; Kawai K; Yamagishi H
Int J Oncol; 2006 Sep; 29(3):531-9. PubMed ID: 16865268
[TBL] [Abstract][Full Text] [Related]
18. A rapid, novel strategy to induce tumor cell-specific cytotoxic T lymphocyte responses using instant dentritomas.
Holmes LM; Li J; Sticca RP; Wagner TE; Wei Y
J Immunother; 2001; 24(2):122-9. PubMed ID: 11265769
[TBL] [Abstract][Full Text] [Related]
19. Generation of populations of antigen-specific cytotoxic T cells using DCs transfected with DNA construct encoding HER2/neu tumor antigen epitopes.
Kuznetsova M; Lopatnikova J; Khantakova J; Maksyutov R; Maksyutov A; Sennikov S
BMC Immunol; 2017 Jun; 18(1):31. PubMed ID: 28633645
[TBL] [Abstract][Full Text] [Related]
20. Cetuximab ± chemotherapy enhances dendritic cell-mediated phagocytosis of colon cancer cells and ignites a highly efficient colon cancer antigen-specific cytotoxic T-cell response in vitro.
Correale P; Botta C; Cusi MG; Del Vecchio MT; De Santi MM; Gori Savellini G; Bestoso E; Apollinari S; Mannucci S; Marra M; Abbruzzese A; Aquino A; Turriziani M; Bonmassar L; Caraglia M; Tagliaferri P
Int J Cancer; 2012 Apr; 130(7):1577-89. PubMed ID: 21618510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
